Insider Trading Activity For Abbott Laboratories (NYSE:ABT)
Brian J Blaser , Insider of Abbott Laboratories (NYSE:ABT) reportedly Sold 15,000 shares of the company’s stock at an average price of 50 for a total transaction amount of $750,000.00 SEC Form
Insider Trading History For Abbott Laboratories (NYSE:ABT)
Analyst Ratings For Abbott Laboratories (NYSE:ABT)
These are 3 Hold Ratings, 10 Buy Ratings .
The current consensus rating for Abbott Laboratories (NYSE:ABT) is Buy (Score: 2.77) with a consensus target price of $52.58 , a potential (5.99% upside)
Analyst Ratings History For Abbott Laboratories (NYSE:ABT)
- On 1/29/2016 William Blair Downgraded rating Outperform to Market Perform
- On 1/29/2016 Raymond James Financial, Inc. Lower Price Target of rating Outperform with a price target of $46.00 to $42.00
- On 3/28/2016 Leerink Swann Boost Price Target of rating Market Perform with a price target of $37.00 to $40.00
- On 4/14/2016 First Global Downgraded rating Outperform to Marketperform
- On 4/28/2016 Piper Jaffray Companies Downgraded rating Overweight to Neutral
- On 4/30/2016 Gabelli Reiterated Rating Buy
- On 4/30/2016 S&P Equity Research Reiterated Rating Hold
Dividend Information For Abbott Laboratories (NYSE:ABT)
Abbott Laboratories (NYSE:ABT) pays an annual dividend of Community Ranking: with a yield of 2.14% and an average dividend growth of 22.90% (3 Year Average).
Dividend History For Abbott Laboratories (NYSE:ABT)
Recent Trading Activity for Abbott Laboratories (NYSE:ABT)
Shares of Abbott Laboratories closed the previous trading session at 49.61 down -0.50 -1.00% with 5,688,266 shares trading hands.